This page includes the latest FDA filings for Nymox Pharmaceutical Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| CANADA | NASDAQ | NYMX | DUNS 253307326 |
| Registration Number | 3003611012 |
| FEI Number | 3003611012 |
| Name | NYMOX PHARMACEUTICAL CORPORATION |
| Owner & Operator | NYMOX CORPORATION |
| Contact Address | 777 TERRACE AVE., 3RD FL. -- Hasbrouck Heights NJ 07604 US |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | 9900 CAVENDISH BLVD. SUITE 206 ST.-LAURENT Quebec, H4M 2V2 CA |
| Establishment Type | Develop Specifications But Do Not Manufacture At This Facility |
Device Company | Device | Date |
|---|---|---|
NYMOX PHARMACEUTICAL CORPORATION [NYMOX CORPORATION] | NicAlert | 2007-12-11 |
NYMOX PHARMACEUTICAL CORPORATION [NYMOX CORPORATION] | NicAlert | 2007-12-11 |
NYMOX PHARMACEUTICAL CORPORATION | NICALERT | 2002-10-18 |
| SEC | 0001018735 | NYMOX PHARMACEUTICAL CORP |